2009 - National Institutes of Health Director's Pioneer Award
Her scientific interests lie mostly in Immunology, Cytotoxic T cell, Molecular biology, Immune system and Interleukin 21. Her Immunology research is multidisciplinary, incorporating elements of Carcinogenesis, Intestinal mucosa and Cell biology. Hilde Cheroutre interconnects MHC class I and CD8 in the investigation of issues within Cell biology.
Her Cytotoxic T cell research is multidisciplinary, incorporating perspectives in T cell, Cancer and Major histocompatibility complex. Her Immune system study integrates concerns from other disciplines, such as Proinflammatory cytokine, Cytokine and Evolutionary biology. The various areas that Hilde Cheroutre examines in her Interleukin 21 study include CD28, FOXP3 and Antigen-presenting cell.
Her primary areas of study are Immunology, Cell biology, T cell, Antigen and Immune system. Her research related to Intraepithelial lymphocyte, CD8, T-cell receptor, MHC class I and Effector might be considered part of Immunology. Her Cell biology research is multidisciplinary, relying on both Cellular differentiation, Receptor, Cytotoxic T cell, Major histocompatibility complex and Retinoic acid.
Her work on Cytokine expands to the thematically related T cell. Her research in Antigen intersects with topics in Molecular biology, Leukemia, Signal transduction and Inflammatory bowel disease. Her Immune system research incorporates themes from Proinflammatory cytokine, Intestinal mucosa and Lymphocyte.
Her primary scientific interests are in Cell biology, Immunology, Cytotoxic T cell, T cell and Immune system. Her Cell biology study combines topics from a wide range of disciplines, such as Agonist, Innate lymphoid cell, Intraepithelial lymphocyte and T-cell receptor. Her biological study deals with issues like Receptor, which deal with fields such as Signal transduction.
The T cell study combines topics in areas such as CD8 and Cellular differentiation. The concepts of her Immune system study are interwoven with issues in Nuclear receptor, Antibody, Retinoic acid and Lymphocyte. Her studies examine the connections between Antigen-presenting cell and genetics, as well as such issues in Interleukin 21, with regards to Natural killer T cell.
Hilde Cheroutre focuses on Immunology, Cell biology, T cell, Major histocompatibility complex and Innate immune system. Her research links Macrophage with Immunology. Her study brings together the fields of Receptor and Cell biology.
Her Major histocompatibility complex research integrates issues from Cytotoxic T cell and T-cell receptor. Her studies deal with areas such as Acquired immune system, Interleukin 23, Cytokine and Immunity as well as Innate immune system. Her Immune system research incorporates elements of Nuclear receptor, Intestinal mucosa and Tretinoin.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid.
Daniel Mucida;Yunji Park;Gisen Kim;Olga Turovskaya.
IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
Sergei Grivennikov;Eliad Karin;Janos Terzic;Janos Terzic;Daniel Mucida.
Cancer Cell (2009)
Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth.
Sergei I. Grivennikov;Kepeng Wang;Daniel Mucida;C. Andrew Stewart.
Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis
Masako Murai;Olga Turovskaya;Gisen Kim;Rajat Madan.
Nature Immunology (2009)
The light and dark sides of intestinal intraepithelial lymphocytes
Hilde Cheroutre;Florence Lambolez;Daniel Mucida.
Nature Reviews Immunology (2011)
Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis.
Diana M. Shih;Yu-Rong Xia;Xu-Ping Wang;Elizabeth Miller.
Journal of Biological Chemistry (2000)
Overexpression of Interleukin-10 by Activated T Lymphocytes Inhibits Atherosclerosis in LDL Receptor–Deficient Mice by Altering Lymphocyte and Macrophage Phenotypes
Laura J. Pinderski;Michael P. Fischbein;Ganesamoorthy Subbanagounder;Michael C. Fishbein.
Circulation Research (2002)
Molecular cloning of human interleukin 2 cDNA and its expression in E. coli
Rene Devos;Geert Plaetinck;Hilde Cheroutre;Guus Simons.
Nucleic Acids Research (1983)
Altered immune responses in interleukin 10 transgenic mice.
Amy Hagenbaugh;Sherven Sharma;Steven M. Dubinett;Sherry H.-Y. Wei.
Journal of Experimental Medicine (1997)
Transcriptional reprogramming of mature CD4+ helper T cells generates distinct MHC class II-restricted cytotoxic T lymphocytes
Daniel Mucida;Mohammad Mushtaq Husain;Sawako Muroi;Femke Van Wijk.
Nature Immunology (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: